Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
The RV411 study group(Thai Red Cross Society), Donn Colby(Thai Red Cross Society), Lydie Trautmann(Henry M. Jackson Foundation), Suteeraporn Pinyakorn(Henry M. Jackson Foundation), Louise Leyre(Centre Hospitalier de l’Université de Montréal), Amélie Pagliuzza(Thai Red Cross Society), Eugène Kroon(Thai Red Cross Society), Morgane Rolland(Henry M. Jackson Foundation), Hiroshi Takata(Henry M. Jackson Foundation), Supranee Buranapraditkun(Henry M. Jackson Foundation), Jintana Intasan(Thai Red Cross Society), Nitiya Chomchey(Thai Red Cross Society), Roshell Muir(Drexel University), Elias K. Haddad(Drexel University), Sodsai Tovanabutra(Henry M. Jackson Foundation), Sasiwimol Ubolyam(HIV Netherlands Australia Thailand Research Collaboration), Diane L. Bolton(Leidos (United States)), Brandie Fullmer(Leidos (United States)), Robert J. Gorelick(Leidos (United States)), Lawrence Fox(National Institute of Allergy and Infectious Diseases), Trevor A. Crowell(Henry M. Jackson Foundation), Rapee Trichavaroj(Armed Forces Research Institute of Medical Science), Robert J. O’Connell(Centre Hospitalier de l’Université de Montréal), Nicolas Chomont(Centre Hospitalier de l’Université de Montréal), Jérôme H. Kim(International Vaccine Institute), Nelson L. Michael(Walter Reed Army Institute of Research), Merlin L. Robb(Henry M. Jackson Foundation), Nittaya Phanuphak(Thai Red Cross Society), Jintanat Ananworanich(Henry M. Jackson Foundation)
Cited by 332Open Access
Abstract
Related Papers
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Tae‐Wook Chun, Lieven Stuyver, Stephanie B. Mizell et al.|Proceedings of the National Academy of Sciences|1997|2k